AzTrials
AzTrials

HyperglycemiaNCT01488383

Effect of Stevioside in Postpandrial Glucose in Healthy Adults

A study testing Purified extract of Rebaudina Stevia-Stevioside and Sodium saccharin in people with Hyperglycemia and Hypertension, run by Basque Health Service at 1 site in Spain.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

A natural sweetener (Stevia Rebaudina Bertoni) reduces blood glucose levels and blood pressure according to various preclinical and clinical studies conducted worldwide. Since it is not found many studies in the literature wich compares Stevia Rebaudiana with saccharin, we've proposed a randomized crossover clinical… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Hyperglycemia, Hypertension
What is being tested?
Purified extract of Rebaudina Stevia-Stevioside and Sodium saccharin
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteSpain
Study dates
Sep 2013to Sep 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Professionals of sanitary centers in active working situation at start date of clinical trial.
  • Weight over 50kg.
  • Age over 18 years.

Who cannot join

  • History of diabetes mellitus, arterial hypertension or hypercholesterolemia.
  • Obesity (BMI ≥ 30kg/m2)
  • Cardiovascular disease.
  • Enrollment in other clinical trial with medicaments within three months.
  • Any endocrine disease other than diabetes.
  • Glucocorticoids treatment.
Show all 12Show fewer
  • Pregnant women.
  • Herball allergy.
  • Autoimmune diseases.
  • Inflammatory bowel disease.
  • Allergy to sulfonamides.
  • Steven-Johnson syndrome.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Basque Public Health Service-Osakidetza (Lakuabizkarra primary care center and Txagorritxu hospital)

    Vitoria-Gasteiz, Alava, 01009

Other trials in Spain

About this study

Official title: Comparison of the Effect on Postpandrial Capillary Blood Glucose Between Oral Stevioside Versus Saccharin in Healthy Adults.

A natural sweetener (Stevia Rebaudina Bertoni) reduces blood glucose levels and blood pressure according to various preclinical and clinical studies conducted worldwide. Since it is not found many studies in the literature wich compares Stevia Rebaudiana with saccharin, we've proposed a randomized crossover clinical trial comparing the effects on postprandial capillary blood glucose and blood pressure in healthy adults.

Sample: healthy professionals from two health centers in Alava (Kakuabizkarra primary care center and Txagorritxu hospital). Inclusion criteria: Professionals of two health centers of Álava (Lakuabizkarra and Txagorritxu) and active employment status at the beginning of the trial, weighing more than 50kg and age over 18 years.

Read more

Intervention: 200mg capsules of Stevia or 250mgcapsules of saccharin. Measurements: Capillary blood glucose and blood pressure, fasting and after eating. Evaluation of satiety, hunger and fullness by questionnaire after intake, and at the end of the day.

Statistical analysis: Compare the postprandial capillary glucose levels between 8 am and 1 st hour, 2nd hour 3rd hour after intake between treatments by ANCOVA. We will also compare blood pressure before and after intake between treatments. We will also compare by t test or paired Wilcoxom (depending on the nature of the variable) the results of the questionnaire after intake between treatments.

Read the detailed description

State of the art: Excessive intake of calories and sugar diets cause weight gain and impaired glucose tolerance in healthy subjects (1). These diets raise postpandrial blood glucose and insulin levels and cause metabolic and hormonal changes that induce feelings of hunger and fat deposition. These diets are also associated with diseases such as diabetes, cardiovascular disease and cancer (2).

The origin of the artificial sweeteners dates back to 1879 with the accidental discovery of saccharin. France in 1902 and the United States in 1912 officially banned its use because of their lack of nutritional value. But Europe allowed the use of saccharin during sugar rationing in the world wars (3). In the past three decades has increased the consumption of these sweeteners as it has allowed many people suffering from obesity and / or diabetes restore some degree of palatability to foods (4).

Stevia rebaudiana Bertoni (Bertoni), common name "sweet herb of Paraguay" is a plant native to Paraguay and Brazil, known by Indians as Ka'a-he'e (sweet grass). Its leaves were used since pre-Columbian times for medicinal purposes and as a sweetener because of its sweet taste (5). Japan and Brazil have more than 20 years using it as a natural sweetener. The main sweet component of Stevia is the Stevioside, a glycoside 300 times sweeter than sucrose (7).

The benefits of stevia as a dietary supplement in humans are many: it is stable, non-caloric and offers a good dental health. In addition, no significant adverse effects have occurred from their use (6).

There have been several studies that compare the decline in blood glucose and insulin levels of Stevia versus many sweeteners. It has been administered to healthy and diabetic rats (8), healthy humans (9,10), obese (10) and diabetic (11).

Another therapeutic properties of Stevia rebaudiana is a reduction in blood pressure, systolic and diastolic as Chan et al demonstrated in a randomized clinical trial conducted in China (12,13).

Toxicity studies in animals (14) and pregnant (15) have concluded that consumption of Stevia is safe at commonly used doses of sweetener (7). Furthermore, the quality of life did not deteriorate (12) nor adverse effects have been detected (16).

The available data suggest that stevia has immunostimulatory activity and inflammation modulating. But these effects have not been demonstrated in a robust in animal models or cell lines. If confirmed, the used of stevia could cause problems in some subgroups of population like in people with autoimmune diseases or gastrointestinal tract inflammation (6).

In USA it is used as a dietary supplement since 1995, but was evaluated as a sweetener by the European Scientific Committee on Food for 1984, 1989 and 1999 and concluded that it was not toxicologically acceptable because there were not enough studies (6). However, recently, the FDA, WHO and FAO have approved Stevia as a "food additive" for use in people of all ages (17).

In summary, the literature indicates that steviol can be used safely as a sweetener in the healthy population, and brings significant benefits for controlling blood glucose levels and blood pressure. However, to date there are few studies comparing Stevia with other common sweeteners. For this reason, and to compare the effect of saccharin versus Stevioside, we plan to conduct this randomized crossover clinical trial.

Study justification: Diets high in sucrose promote weight gain, causing alterations in glucose tolerance in healthy subjects (1) and are associated with metabolic disorders like diabetes wich is characterized by plasma glucose levels above the normal limits and if it isn't adequately treated can lead to complications such as neuropathy, retinopathy, neuropathy, diabetic microangiopathy and atherosclerosis.

Since diabetic patients should not eat sugar, artificial sweetener use has increased over the past three decades due to the fact that consumption of these substances has allowed many people suffering from obesity and /or diabetes to restore some degree of palatability to food (4). Among them, a natural sweetener, Stevioside also reduces the levels of postprandial glucose and insulin, and blood pressure. Besides the consumption of Stevia is safe at doses normally used as a sweetener

According to the reviewed literature, Stevioside can be used safely as a sweetener in the healthy population, providing significant benefits for controlling blood glucose levels and blood pressure with no serious adverse reactions. In the most of studies from literature, Stevioside's effect is compared with placebo, however, to date few studies have been conducted wich compare it with other sweeteners commonly used by people. For this reason, and to compare the effect and safety of Stevioside versus Saccharin we have planed this randomized crossover clinical trial.

Being tested
Purified extract of Rebaudina Stevia-Stevioside, Sodium saccharin
Keywords
Hyperglycemia, Diabetes, Blood glucose, Hypertension, Anti hypertensive agents, Anti hypertensive drugs, Anti hypertensive
Medical subject headings
Hyperglycemia, Hypertension, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Purified extract of Rebaudina Stevia-SteviosideDrug

    Also called Gycostevia-95

    volunteers will take only one capsule of stevioside (one day), and then corresponding measurements will be performed.

  • Sodium saccharinDrug

    Also called Saccharin

    Volunteers will take one capsule of saccharin 250mg (one day) and then, corresponding measurements will be performed

Study groups in NCT01488383
Study groupRoleWhat they receive
Stevioside capsules 200mgExperimentalCapsules of 200mg Stevioside
Receives: Drug: Purified extract of Rebaudina Stevia-Stevioside
Sodium Saccharin 250 capsulesActive comparatorCapsules of 250mg Saccharin
Receives: Drug: Sodium saccharin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in capillary blood glucose levels

    Change in capillary blood glucose levels after treatment

    Measured: at baseline and and at first hour after intake

Secondary outcomes (3)
  1. change in blood pressure

    Change in blodd pressure after treatment

    Measured: at baseline and and at third hour after intake

  2. feeling of fullness, hunger and satiety after intake

    feeling of fullness, hunger and satiety after treatment

    Measured: At baseline and and at third hour after intake

  3. Adverse reactions of treatments (nausea, diarrhea, vomiting, allergic signs)

    To describe and compare the adverse reactions of each treatment nausea, diarrhea, vomiting, allergic signs.

    Measured: After intake

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2011 (estimated)
  2. Study startSep 2013
  3. Primary completionSep 2013 (estimated)
  4. Study completionSep 2013 (estimated)

Why it stopped: not i

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01488383
Sponsor's protocol ID
ST-01
Status last verified
Sep 2015
First submitted
7 Dec 2011
Last updated
9 Sep 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Purified extract of Rebaudina Stevia-Stevioside and Sodium saccharin in people with Hyperglycemia and Hypertension, run by Basque Health Service at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 9 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in capillary blood glucose levels (time frame: at baseline and and at first hour after intake). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in